Form 4: NHI CEO Exercises Options, Boosts Stock Holdings
Insider Transaction Report
National Health Investors CEO D. Eric Mendelsohn exercised stock options and adjusted his direct beneficial ownership of common stock, increasing his net holdings by 16,372 shares.
Summary
- D. Eric Mendelsohn, CEO, President, and Director of National Health Investors Inc. (NHI), reported changes in his beneficial ownership of common stock.
- On January 15, 2026, Mendelsohn exercised a total of 151,667 stock options.
- The exercised options had various exercise prices, including $69.2 for 125,000 shares, $54.73 for 13,334 shares, and $57.76 for 13,333 shares.
- Concurrently, 135,295 shares of common stock were disposed of at a price of $79.23, likely to cover exercise costs and tax obligations.
- Following these transactions, Mendelsohn's direct beneficial ownership of NHI common stock increased by a net of 16,372 shares, resulting in a total of 112,505 shares.
- The transactions were conducted pursuant to a Rule 10b5-1(c) plan, indicating they were pre-arranged.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to the CEO's net increase in beneficial ownership, indicating continued confidence in the company, despite the disposition of shares for tax purposes. The transactions being under a 10b5-1 plan also adds a layer of neutrality/pre-planning.
Positives
- The CEO exercised a significant number of stock options, indicating continued confidence in the company's long-term prospects.
- The net increase in beneficial ownership by 16,372 shares suggests a continued alignment of management's interests with shareholders.
- Transactions were made under a Rule 10b5-1(c) plan, indicating pre-planned and not opportunistic trading.
Negatives
- A substantial number of shares (135,295) were disposed of, which, while common for tax/cost coverage, represents a reduction in direct holdings from the gross shares acquired.
Future Outlook
The filing does not contain specific forward-looking statements or guidance regarding the company's future performance, as it is a report on insider transactions scheduled for a future date.
Industry Context
Insider transactions, such as option exercises and subsequent share adjustments, are common in the REIT sector, particularly for executives whose compensation packages often include equity-based incentives. These transactions reflect individual compensation events rather than broader industry trends, though a net increase in insider holdings can be seen as a positive signal of management confidence within the healthcare REIT space.
Stakeholder Impact
- Shareholders: The net increase in CEO's beneficial ownership may be viewed positively as it aligns management's interests with shareholder value. The disposition of shares for tax purposes is a routine event and generally not seen as a negative signal.
- Employees: No direct impact on employees is indicated by this filing.
- Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 02/25/2021 | Date when 41,666 stock options with an exercise price of $69.2 became exercisable. |
| 02/25/2022 | Date when 41,666 stock options with an exercise price of $69.2 became exercisable. |
| 02/25/2023 | Date when 41,668 stock options with an exercise price of $69.2 became exercisable. |
| 02/24/2025 | Date when 13,334 stock options with an exercise price of $54.73 became exercisable. |
| 02/23/2025 | Date when 13,333 stock options with an exercise price of $57.76 became exercisable. |
| 01/15/2026 | Date of all reported transactions, including the exercise of stock options and disposition of common stock. |
| 01/16/2026 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
| 02/25/2026 | Expiration date for 125,000 stock options (three tranches of 41,666, 41,666, and 41,668 shares). |
| 02/24/2028 | Expiration date for 13,334 stock options. |
| 02/23/2029 | Expiration date for 13,333 stock options. |
Recommendation
holdThis Form 4 filing details routine insider transactions involving the exercise of stock options and a subsequent 'sell to cover' for tax obligations by the CEO. While the net increase in beneficial ownership by 16,372 shares is a positive signal of management's continued alignment with shareholder interests, it does not provide new fundamental information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transactions were pre-planned under a Rule 10b5-1(c) plan, further suggesting they are not based on new, material non-public information. Therefore, a 'hold' recommendation is appropriate, maintaining current positions while awaiting more substantive corporate updates.
Keywords
National Health Investors, NHI, D. Eric Mendelsohn, Insider Trading, Stock Options, Beneficial Ownership, Form 4, CEO, Director, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.